April 18, 2023

ByPro Nutrition LLC – 646308 – 04/04/2023

Delivery Method: VIA UNITED PARCEL SERVICE Product: DrugsFood & Beverages Recipient: Recipient Name Dr. Robert L Bynum Recipient Title Owner ByPro Nutrition LLC 1906 Potomac Dr.Columbia, […]
April 18, 2023

Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy – 653740 – 03/31/2023

Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Rob Kilgore Recipient Title CEO Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy 12860 W. […]
April 18, 2023

Eco Lips, Inc. – 631629 – 09/20/2022

Delivery Method: UPS Product: Drugs Recipient: Recipient Name Glen A. Jasper Recipient Title President and Chief Sales Officer Eco Lips, Inc. 6000 Huntington Ct. NECedar Rapids, […]
April 17, 2023

FDA CDER and CBER & Duke-Margolis Center for Health Policy | Rare Disease Endpoint Advancement Pilot Program Workshop: Novel Endpoints for Rare Disease Drug Development – 06/07/2023

On This Page Date: June 7 – 8, 2023 Day1: Wed, Jun 7 1:00 PM – 5:00 PM ET Day2: Thu, Jun 8 1:00 PM – […]
April 14, 2023

Drug Trial Snapshot: EMPAVELI

What are the possible side effects (results of trials used to assess safety)? The table below summarizes adverse reactions in the Trial APL2-302. Treatment-Emergent Adverse Events […]
April 14, 2023

Auro Pharmacies, Inc. – 608369 – 04/11/2023

Delivery Method: Via Email Delivery Confirmation Product: Drugs Recipient: Recipient Name Dr. Nayan Patel Recipient Title CEO Auro Pharmacies, Inc. 520 W La Habra Blvd.La Habra, […]
April 13, 2023

Public Notification: AK Forte contains hidden drug ingredients

[4-13-2023] The Food and Drug Administration is advising consumers not to purchase or use AK Forte, a product promoted and sold for joint pain and arthritis […]
April 13, 2023

All Opioid Pain Medicines: Drug Safety Communication – FDA Updates Prescribing Information to Provide Additional Guidance for Safe Use

[Posted 04/13/2023]  AUDIENCE: Patient, Health Professional, Pain Management, Pharmacy, Caregivers   ISSUE: The FDA is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long […]
April 13, 2023

An Update on Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR) – 05/24/2023

On This Page Date: May 24, 2023 Time: 9:00 AM – 2:00 PM ET Agenda Visit CDER Small Business and Industry Assistance Page ABOUT THIS WEBINAR […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0